CME Group Inc. $CME Stock Bought by Krilogy Financial LLC

Krilogy Financial LLC increased its holdings in CME Group Inc. (NASDAQ:CME) by 205.7% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 6,220 shares of the financial services provider’s stock after purchasing an additional 4,185 shares during the period. Krilogy Financial LLC’s holdings in CME Group were worth $1,630,000 as of its most recent filing with the SEC.

Several other large investors also recently bought and sold shares of CME. Mechanics Bank Trust Department purchased a new stake in shares of CME Group during the 3rd quarter valued at about $282,000. Forvis Mazars Wealth Advisors LLC bought a new stake in shares of CME Group in the third quarter worth approximately $905,000. Accel Wealth Management bought a new stake in shares of CME Group in the third quarter worth approximately $634,000. Contravisory Investment Management Inc. purchased a new position in shares of CME Group during the third quarter valued at approximately $184,000. Finally, Downshift Financial LLC raised its holdings in shares of CME Group by 47.7% during the third quarter. Downshift Financial LLC now owns 189 shares of the financial services provider’s stock valued at $50,000 after purchasing an additional 61 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other CME Group news, Director William R. Shepard bought 293 shares of CME Group stock in a transaction on Friday, September 25th. The stock was acquired at an average cost of $268.76 per share, with a total value of $78,746.68. Following the completion of the acquisition, the director owned 263,289 shares in the company, valued at approximately $70,761,551.64. This represents a 0.11% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Elizabeth A. Cook sold 500 shares of the stock in a transaction that occurred on Monday, September 14th. The stock was sold at an average price of $280.11, for a total transaction of $140,055.00. Following the completion of the transaction, the director owned 17,916 shares in the company, valued at $5,018,450.76. The trade was a 2.72% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.30% of the stock is currently owned by insiders.

CME Group Trading Up 1.4%

Shares of NASDAQ:CME opened at $289.46 on Friday. The stock has a market capitalization of $104.08 billion, a price-to-earnings ratio of 24.55, a PEG ratio of 3.74 and a beta of 0.24. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The stock’s 50-day simple moving average is $273.52 and its two-hundred day simple moving average is $270.60. CME Group Inc. has a 52-week low of $218.31 and a 52-week high of $329.16.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.91 by $0.08. CME Group had a return on equity of 15.60% and a net margin of 63.30%. The business had revenue of $1.71 billion during the quarter, compared to the consensus estimate of $1.68 billion. During the same period in the previous year, the company posted $2.96 EPS. The business’s quarterly revenue was up .8% compared to the same quarter last year. Analysts expect that CME Group Inc. will post 12.29 EPS for the current year.

CME Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 25th. Investors of record on Wednesday, September 9th were issued a $1.30 dividend. The ex-dividend date of this dividend was Wednesday, September 9th. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.8%. CME Group’s dividend payout ratio (DPR) is presently 44.11%.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on CME. Wells Fargo & Company increased their price objective on shares of CME Group from $301.00 to $315.00 and gave the company an “overweight” rating in a research report on Wednesday. Piper Sandler cut their target price on shares of CME Group from $329.00 to $295.00 and set an “overweight” rating for the company in a research report on Wednesday, July 15th. TD Cowen lifted their target price on shares of CME Group from $292.00 to $300.00 and gave the stock a “buy” rating in a research report on Monday, October 5th. Raymond James Financial reiterated an “outperform” rating and set a $320.00 target price on shares of CME Group in a research note on Thursday, July 2nd. Finally, Weiss Ratings raised CME Group from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, October 8th. Nine equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $292.94.

CME Group Profile

CME Group Inc operates global derivatives marketplaces that enable customers to manage risk and trade futures and options contracts. Its exchanges offer products linked to interest rates, equity indexes, foreign currencies, agricultural commodities, energy, metals and other asset classes.

The company also provides central counterparty clearing, settlement and related risk-management services for transactions conducted on its markets. In addition, CME Group offers market data, benchmark products and technology services that support trading, analysis and connectivity for financial institutions, businesses, professional traders and other market participants.

CME Group’s history includes the Chicago Board of Trade, founded in 1848, and the Chicago Mercantile Exchange, established in 1898.